EGFR and cancer: They serve as impermeable micro-reservoir carriers that enable effective packing of a variety of various medicines, proteins, or nucleic acids; (c) targeting moiety, an anti-EGFR bispecific antibody directs the EDVs to cancer cells that express EGFR (Reid et al. 2016).